NCT06305767 A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06305754 Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06297876 COVIDVaxStories: Randomized Trial to Reduce COVID-19 Vaccine Hesitancy in Populations of Color Status COMPLETED Phase NA
NCT06295809 A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007) Status TERMINATED Phase PHASE2/PHASE3
NCT06295796 A Study of MK-8527 in Participants With Moderate and Severe Renal Impairment (MK-8527-008) Status COMPLETED Phase PHASE1
NCT06294912 A Study to Evaluate Antimalarial Activity and Safety of MK-7602 in Healthy Adults (MK-7602-003) Status COMPLETED Phase PHASE1
NCT06286163 Neuroinflammatory Interactions of ATP and P2X3 Receptor in the Airways of Chronic Cough Patients Status RECRUITING Phase N/A
NCT06285240 Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treatment (MK-1167-007) Status COMPLETED Phase PHASE1
NCT06284590 Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients Status RECRUITING Phase PHASE2
NCT06273774 A Study of Elpipodect (MK-8189) in Participants With Bipolar I Disorder (MK-8189-020) Status COMPLETED Phase PHASE1
NCT06271681 Evaluation of PCV21 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans Status NOT_YET_RECRUITING Phase PHASE4
NCT06266338 Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix) Status RECRUITING Phase PHASE2
NCT06255938 Prevalence of HPV (Human Papilloma Virus) and HPV Vaccination Among Victims of Sexual Violence Status NOT_YET_RECRUITING Phase N/A
NCT06242691 Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors (MK-1200-002) Status COMPLETED Phase PHASE1/PHASE2
NCT06234605 A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma Status RECRUITING Phase PHASE1
NCT06234397 Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT06229353 Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department Status TERMINATED Phase N/A
NCT06212752 A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)-Japan Extension Status ACTIVE_NOT_RECRUITING Phase PHASE3